Elicio Therapeutics, Inc. · NASDAQ:ELTX
GKCC, LLC reported a 48.00% stake in Elicio Therapeutics, Inc. (Schedule 13D/A)
Event Jun 3, 2025 · Filed Jun 4, 2025
GKCC, LLC reported a 48.00% stake in Elicio Therapeutics, Inc., 9,752,139 shares, with active intent on Jun 3, 2025. Filed Jun 4, 2025 (Schedule 13D/A).
- Stake
- 48.00%
- Shares
- 9,752,139
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GKCC, LLC | 48.00% | 9,752,139 |
| Yekaterina Chudnovsky | 48.00% | 9,764,864 |
Source
Related
- Elicio Therapeutics, Inc.
- Gkcc, LLC
- Elicio Therapeutics, Inc. shareholders
- Schedule 13G · Moti Investments LLC · Jul 16, 2026
- Schedule 13G/A · Knoll Capital Management, LLC · Jul 8, 2026
- Schedule 13G/A · Actyus Private Equity SGIIC, S.A. · Oct 7, 2025
- Schedule 13G/A · Actyus Private Equity SGIIC, S.A. · May 14, 2025
- Schedule 13D/A · Chudnovsky Yekaterina · Mar 7, 2025